Enovis beat earnings expectations in its first quarter 2025 results out today, but the market reaction was tempered.

SS Innovations plans to submit a de novo classification request to the U.S. FDA for its SSi Mantra 3 surgical robotic system.

MicroTransponder has reported the results of a one-year follow-up study of its Vivistim Paired VNS System for chronic stroke ...

German medtech giant Siemens Healthineers reduced the lower end of its full-year earnings guidance amid Trump administration ...